| Tamoxifen | Approved Investigational | PGR | 5241 |
downregulated | Tamoxifen results in decreased expression of PGR mRNA | 11q22.1 | |
| Tamoxifen | Approved Investigational | PIM1 | 5292 |
upregulated | Tamoxifen results in increased expression of PIM1 mRNA | 6p21.2 | |
| Tamoxifen | Approved Investigational | PLA2G7 | 7941 |
downregulated | Tamoxifen results in decreased expression of PLA2G7 mRNA | 6p12.3 | |
| Tamoxifen | Approved Investigational | PLEKHM2 | 23207 |
upregulated | Tamoxifen results in increased expression of PLEKHM2 mRNA | 1p36.21 | |
| Tamoxifen | Approved Investigational | POLR2J | 5439 |
upregulated | Tamoxifen results in increased expression of POLR2J mRNA | 7q22.1 | |
| Tamoxifen | Approved Investigational | POU6F1 | 5463 |
downregulated | Tamoxifen results in decreased expression of POU6F1 mRNA | 12q13.13 | |
| Tamoxifen | Approved Investigational | PPARGC1A | 10891 |
upregulated | Tamoxifen results in increased expression of PPARGC1A mRNA | 4p15.2 | |
| Tamoxifen | Approved Investigational | PPP2CA | 5515 |
downregulated | Tamoxifen results in decreased expression of PPP2CA mRNA | 5q31.1 | |
| Tamoxifen | Approved Investigational | PRF1 | 5551 |
downregulated | Tamoxifen results in decreased expression of PRF1 mRNA | 10q22.1 | |
| Tamoxifen | Approved Investigational | PRF1 | 5551 |
upregulated | [Tamoxifen results in increased expression of TGFB1 protein] which results in increased expression of PRF1 mRNA | 10q22.1 | |
| Tamoxifen | Approved Investigational | PRPF4B | 8899 |
upregulated | Tamoxifen results in increased expression of PRPF4B mRNA | 6p25.2 | |
| Tamoxifen | Approved Investigational | PRPS1L1 | 221823 |
downregulated | Tamoxifen results in decreased expression of PRPS1L1 mRNA | 7p21.1 | |
| Tamoxifen | Approved Investigational | PTGS2 | 5743 |
upregulated | [Tamoxifen results in increased activity of ESR1 protein] which results in increased expression of PTGS2 mRNA | 1q31.1 | |
| Tamoxifen | Approved Investigational | PTK2B | 2185 |
downregulated | Tamoxifen results in decreased expression of PTK2B mRNA | 8p21.2 | |
| Tamoxifen | Approved Investigational | PTPRO | 5800 |
upregulated | Tamoxifen results in increased expression of PTPRO mRNA | 12p12.3 | |
| Tamoxifen | Approved Investigational | RAB40C | 57799 |
upregulated | Tamoxifen results in increased expression of RAB40C mRNA | 16p13.3 | |
| Tamoxifen | Approved Investigational | RASEF | 158158 |
downregulated | Tamoxifen results in decreased expression of RASEF mRNA | 9q21.32 | |
| Tamoxifen | Approved Investigational | RCAN1 | 1827 |
upregulated | Tamoxifen results in increased expression of RCAN1 mRNA | 21q22.12 | |
| Tamoxifen | Approved Investigational | RGS9 | 8787 |
downregulated | Tamoxifen results in decreased expression of RGS9 mRNA | 17q24.1 | |
| Tamoxifen | Approved Investigational | RND2 | 8153 |
downregulated | Tamoxifen results in decreased expression of RND2 mRNA | 17q21.31 | |
| Tamoxifen | Approved Investigational | RND3 | 390 |
upregulated | Tamoxifen results in increased expression of RND3 mRNA | 2q23.3 | |
| Tamoxifen | Approved Investigational | RPS15 | 6209 |
upregulated | Tamoxifen results in increased expression of RPS15 mRNA | 19p13.3 | |
| Tamoxifen | Approved Investigational | RRP9 | 9136 |
upregulated | Tamoxifen results in increased expression of RRP9 mRNA | 3p21.2 | |
| Tamoxifen | Approved Investigational | RSAD2 | 91543 |
upregulated | Tamoxifen results in increased expression of RSAD2 mRNA | 2p25.2 | |
| Tamoxifen | Approved Investigational | RUNX1 | 861 |
upregulated | Tamoxifen results in increased expression of RUNX1 mRNA | 21q22.12 | |